and FSH [18, 21, 24, 42, 44, 48, 63] . Kanitz et al. [32] showed for FSH that with increasing doses the number of ovulations increases significantly until a plateau was reached for the parameter. It was not possible to increase ovulation number
DOSE-RESPONSE RELATIONS
The ovulation number and the following number of recovered oocytes and embryos show a dose-dependent pattern. This was partly or fully shown for hMG [47] , eCG with further increasing FSH doses. On the contrary, very high FSH doses were followed by a depression in ovulation number ( Fig. 1) as shown for eCG [56] . The mechanisms responsible for the decrease in ovulation number are not well understood. Saumande and Chupin [57] speculate that the depression of ovulations is more dependent on the type of gonadotropin than on the FSH/LH ratio. In our experiments we found that high FSH doses can disturb the ovulation process at two levels, at the level of the pituitary and at the ovarian level. On the one hand, the portion of animals with an LH surge decreased. On the other hand, the number of follicles, which ovulated after an LH surge decreased (Tab. I). Increased progesterone concentrations during oestrus are involved, at least in the depression of an LH surge by inhibiting the development of the positive estrogen feedback. Another reason for a reduced ovulation number may consist in a downregulation of follicular FSH receptors by high doses of the homologous ligand. The results of a field trial with a uniform application and insemination schedule allow the conclusion that each FSH product has an optimal dose range ( Fig. 2 ).
BIOACTIVITY OF FSH PRODUCTS
Different pharmaceutical products with gonadotropins as their active substance and moreover batches of one product can differ in their bioactivity and/or immunoactivity [4, 6, 19, 43] . The reasons consist in the differences in the specific protein content and in the different bioactivities of the gonadotropin which depend on the degree of glycosilation of the molecules and on the occurrence of the isoforms [9, 15, 45, 62, 68, 80] . Although such differences have been well known for many years, no data have been available regarding their consequences on superovulation results. We examined the bioactivity of four different batches of one commercially available FSH product with an in vivo bioassay [4] . The relative bioactivity was in the range of 78.9% to 127.8%. The four batches were used for superovulation. Dairy cows (n = 525) from day 60 to 90 after calving received eight injections of FSH (total amount 24 mg) in decreasing doses from day 10 to 12 of the oestrous cycle. PGF 2a was given 48 and 60 h after the first FSH injection. Thereafter either the structure or the function of the hormones [49] . The results of determination of FSH and LH contents in different FSH products or the activities of the hormones cannot be compared between products because different assays and different standard hormones are often used. The more important question is the possible biological effect of the so called FSH/LH ratio. Donaldson et al. [19] , Beckers [3] , Chupin et al. [11] , Gonzales et al. [24] , Tribulo et al. [67] , and Yamamoto et al. [79] showed that FSH products with reduced LH content give higher ovulation number, fertilisation rate and embryo quality. It is speculated [29] that "high" LH activities cause luteinisation of follicles, receptor down regulation and premature ovulations. "Low" LH activities should cause deviation in oocyte maturation, all cattle were time-oriented inseminated. FSH batches were used independent of the relative bioactivity. The results of superovulatory treatment were significantly influenced by the bioactivities of the batches (Tab. II). The mean fertilisation rates did not differ significantly between the groups.
FSH/LH RATIO
FSH preparations produced from the pituitaries also contain other biological active substances like LH besides FSH. The amounts of FSH and LH and their activities can be different for different batches of one product and for different products [17, 43, 55] . Determination of the amounts or activities is done with assays which, recognise fertilisation and early embryonic development [29] . Moreover, the "right" FSH/LH ratio should be able to reduce the variability of the superovulatory response. This was the background for requesting FSH products with reduced LH content or highly purified FSH. But the above cited results have not been uncontradicted [52, 71] . Because the effects of FSH/LH ratios are usually assessed in terms of the number or quality of recovered oocytes or embryos after superovulatory treatment we determined the effects of gonadotropin preparations with different FSH/LH ratios on follicular growth, portion of atretic follicles and FSH and LH binding of granulosa cells.
Crossbred heifers (n = 78) were randomly divided into 4 groups. Animals received purified porcine pituitary hormone preparations (Ovaset ® , Sanofi) in a total amount (according NIH-P1 standard) of 0.29 mg FSH (FSH group), 0.29 mg FSH and 0.19 mg LH (FSH/LH group) or 0.19 mg LH (LH group) in a treatment of 6 injections on 3 consecutive days starting on day 10 of the oestrous cycle. Untreated animals (buffered saline, 6 injections) with the same stage of the cycle were used as the control. The ovaries were recovered 76 h after the first injection. Follicles of all ovaries were counted and classified according to size. Altogether 1668 follicles from 49 animals were classified as atretic or nonatretic by a macroscopic method [40] . Granulosa cells from individual follicles (> 2 mm diameter) were analysed by flow cytometry for the detection of FSH and LH binding using an indirect quantitative immunofluorescence technique [FITC-labelled anti-hormone-antibodies (UCB) were used for staining after incubation of the cells with ligands]. Statistical analysis were done by EPICS ELITE (Coulter) or by means of the Statistical Analysis Package SAS ® [33] . The results are summarised below.
FSH and FSH/LH treatments significantly increased the number of medium and large follicles. LH treatment alone was not able to induce follicular growth (Tab. III). FSH binding capacity on granulosa cells was significantly stimulated by the homologous ligand (Fig. 3 ) whereas the LH binding capacity was not significantly different between the groups. Finally, the portion of nonatretic follicles was significantly influenced by hormone treatment (Tab. IV). LH was not necessary for superovulatory treatment, but it was also tolerated to a certain amount without negative effects on superovulatory response (Tab. IV).
In the light of the discussion about the effects of LH in FSH products, the results of superovulation after application of recombinant FSH (rFSH) are interesting. Although the first report of the results [72] was very encouraging, the following data [73] showed, that it was neither possible to increase the number of transferable embryos nor possible to decrease the variance of the results through the application of rFSH. 590 Table II . Relative bioactivity in four batches of one FSH product and results of superovulation and embryo recovery after application of 24 mg FSH per donor independent of bioactivity (n = 525 cows).
Batch
Relative that eCG-and rhFSH-stimulated heifers had the same follicular growth characteristics and equal numbers of follicles > 8 mm in diameter after 3 days of stimulation. But there were considerable differences in steroid production between the groups. rhFSH-treated heifers had lower oestradiol concentrations during the first days of stimulation and lower progesterone concentrations in the period after the LH surge than did the eCG-stimulated animals. Moreover rhFSH-treated heifers had fewer LH pulses than did the eCG-treated heifers and the LH surge occurred later. Multiple ovulations occurred in only three of six rhFSH-treated heifers, but in all four eCG-treated heifers with an LH surge. At 24 h after the LH surge, the percentage of metaphase II stage oocytes with cortical granules distributed close to the oolemma was significantly lower in the rhFSH group (7.3%) than in the eCG group (55.9%). The authors concluded, that the final follicular maturation was impaired in heifers treated with rhFSH, which might be due to the combination of a lack of LH activity in the gonadotrophin preparation and the severe suppression of LH pulsatility. But it has to be considered, that the dose of rhFSH for superovulation of cattle was based on reported doses of human menopausal gonadotropin and rhFSH for human treatment. Moreover Gosselin et al. [26] found that there was no significant correlation between estradiol or progesterone and LH pulse frequency, amplitude and mean concentrations at any time in the control or superovulated animals. Their study demonstrates that superovulation treatment in the cow causes a rapid decrease in the pulsatile release of LH and suggests that this effect is not mediated through the negative feedback actions of estradiol and progesterone.
OVULATION TIME AND TIME-ORIENTED INSEMINATION
To determine the ovulation period (i.e. first ovulation, last ovulation) different direct and indirect methods can be used. The most uncertain direct method is rectal palpation. It only allows to recognise if the animal is in the process of ovulation. With some experience, the number of ovulations can be roughly estimated. The method of endoscopy is much better and allows the sure determination of the first ovulation. Unfortunately it is not possible to detect all ovulations, especially in the cases of high numbers of ovulations when blood is present on the surface of the ovaries during the ovulation period. The use of ultrasound is the most less invasive method. But the first and moreover the last ovulation are not easily detectable. LH determination can be used as an indirect method because the time interval between the LH surge and start of ovulation is relatively constant and in most of the papers shows no large variation. When FSH was used for stimulation of follicular growth, the mean time intervals from induction of luteolysis to LH surge ranged from 44 to 48 h. The standard deviation for the parameter was between 2 and 12 h [27, 41, 75, 76] . We also investigated the time interval from the induction of luteolysis to the LH surge.
Therefore, altogether 39 heifers and cows were treated 8 times with FSH for 4 days starting between day 10 to 12 of the oestrous cycle. PGF 2a was given 48 and 60 h after the first FSH injection. All animals received jugular catheters. Blood samples were drawn via catheters every second hour for LH determination. The mean time interval form PGF 2a to LH surge was 46.5 ± 4.4 h. It was independent of the factor 'heifer' or 'cow'. Based on a 6 hourly endoscopic observation of the ovaries of these animals, we detected the start of ovulations 62 to 68 h after induction of luteolysis. This was in agreement with observations made by others [1, 50] . The authors observed the start of ovulations by means of ultrasound diagnosis 68 to 69 h after the induction of luteolysis. The standard deviation for the parameter was very small. In our investigations and in those of others [14, 41] it took 24-30 h from the LH surge until the start of ovulations.
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After thawing in a water bath (38 °C, 15 s), insemination was done in the uterus. Flushing of the uterus was performed on day 7. Using the time-oriented insemination after superovulation of the cows with FSH, fertilisation rates were above 85% after the first or repeated superovulatory treatment (Tab. V). The fertilisation rates obtained with time-oriented insemination were higher than those between 60 and 70% normally reached under routine conditions [52, 69] . They are comparable with recent results from Dalton et al. [13] . These authors reached an 81% fertilisation rate under experimental conditions in a relatively small group of animals (n = 10 cows) with one insemination 24 h after standing heat. In contrast to our experiments, 50 million sperm cells were used for one insemination.
The time interval from the first to the last ovulation varied from 1.2 to 12 h [1, 41, 50, 77] .
Based on these data, we developed the following scheme for a time-oriented insemination in heifers and cows (Fig. 4) . The time necessary for capacitation of sperm cells from bulls (approximately 6 h) is considered in the scheme. We investigated the fertilisation rate after superovulatory treatment with FSH and time-oriented insemination. Altogether 180 cows were flushed one time after a single superovulatory treatment and 43 cows were flushed 145 times after a repeated superovulatory treatment. All cows were inseminated according to data in Figure 4 . For each insemination, one straw with 20 million sperm cells was used. 
FREQUENCY OF FSH APPLICATION
In most cases FSH is given two times per day for four days [16, 23, 36] . But there have been attempts to decrease the number of injections. Purwantara et al. [51] concluded from their experiments, that treatment with Folltropin once daily for 3 days gives a folliculogenic and superovulatory response similar to a treatment regimen where it is given twice daily for 4 days. Other data [36, 58, 61, 65, 78] suggest that the multiple intramuscular injections of FSH can be replaced by a single injection, given subcutaneously. But data from Callejas [10] show that a single injection of FSH-P was not sufficient enough to give the same results reached with eight injections of the same product. Superovulation can also be induced by a single injection of hMG [64] . Kelly et al. [36] investigated the superovulatory response, estradiol concentrations and follicular populations in regard to single or multiple injections of FSH using two different FSH products. The authors found that estradiol concentrations can be significantly influenced by the frequency of the FSH application and FSH product.
In our own experiments FSH application (Folltropin ® , Vetrepharm, Canada) twice daily for 4 days was compared with an application once a day. Superovulatory treatment was started in Simmental cows between day 8 to 13 of the oestrous cycle. Control animals (group 1) received 8 injections of FSH (total dose: 400 mg). The animals in groups 2 and 3 received only one injection per day for four days. The total dose for FSH was 360 mg in group 2 and 260 mg in group 3. PGF 2a was given 72 and 82 h after the first FSH injection. Insemination was done in the same way in all animals. Our results indicate that FSH application once a day can be as efficient as a twice daily injection (Tab. VI).
FOLLICULAR POPULATION AT THE TIME OF TREATMENT
Response to superovulatory treatment is characterised by a high degree of variation. A review about various factors, which have been reported to influence the response after treatment, is given by Kafi and McGowan [31] . Several authors [28, 30, 48, 70] reported, that the presence of a dominant follicle on the day of initiation of superstimulation decreases the superovulatory response. The ablation of the largest/dominant follicle prior to superovulatory treatment can increase superovulatory response [7, 37, 38, 59] , however under field conditions the results could not be repeated [39] . The ablation of the two largest follicles was as efficient as the ablation of all follicles > 5 mm in diameter [2] . In contrast to this, Bergfelt et al. [5] and Diaz et al. [16] did not find a positive effect of follicle ablation on the superovulatory 594 conclusion from the above-cited results and from the knowledge of follicular dynamics in cattle [14, 20, 34, 53, 74] , it can be expected that the ovulation number after superovulatory treatment depends on the number of follicles, which respond to treatment with proliferation, differentiation and ovulation in a period of 120 hours. The quantity and quality of follicles in this pool (Fig. 5) is the main reason for the variability of the superovulatory response. Different results in the literature can be caused by methods for counting and classifying the follicles (i.e. resolution limit of ultrasound).
CONCLUSIONS FOR PRACTISE
1. To maximise the number of transferable embryos, the applied FSH dose has to be in a product specific optimal range. Comparisons between different FSH products according to this range are not useful because different standards and different assays for estimation of the FSH content or bioactivity of the product are used.
2. A reduced bioactivity of FSH should be considered as one possible reason for insufficient results of the superovulatory treatment. Other factors have to be excluded first.
3. LH contaminations in FSH products are not necessary for successful superovulatory treatments, but contaminations are undoubtedly tolerated to a certain amount without negative effects on the results.
4. Recombinant FSH has no advantage in regard to the mean number of transferable embryos and variance of superovulatory results in comparison to purified FSH from the pituitary. Other factors like BSE or other transmissible diseases are not considered in this conclusion.
5. The knowledge about the ovulation period in superovulated cattle allows successful time-oriented insemination in heifers and cows. Two inseminations are sufficient for high fertilisation rates. It has to be response. From these results it was concluded that exogenous FSH treatment appears to override any systemic inhibitory effect that a persistent dominant follicle may be exerting on the pituitary and possibly the ovaries. The opposing results from the different studies can be partly explained by the different time intervals between follicle ablation and superstimulation, by the different time points for ablation (growing phase, static phase or decline phase of the dominant follicle) and by the different criteria for the evaluation of the results.
Several authors [8, 54] found that a high number of potential recruitable follicles is associated with a better superovulatory response. Kawamata [35] determined the relationships between the number of small follicles prior to superovulatory treatment and the superovulatory response. A total of 55 superovulations were induced in Holstein cows. The ovaries were examined ultrasonographically once 0-1.5 days before the initiation of the superovulatory treatment. The number of small follicles 3-6 mm in diameter on both ovaries before the superovulatory treatment was found to be significantly correlated with the numbers of corpora lutea after superovulation (r = 0.440, P < 0.001), total recovered ova (r = 0.503, P < 0.001) and transferable recovered embryos (r = 0.482, P < 0.001). More recently, Cushmann et al. [12] found that the number of CL is correlated positively with the total number of primordial, tertiary, and medium surface follicles. The number of CL is related to the number of tertiary follicles in a positive linear manner and the number of medium follicles in a positive quadratic manner. In contrast to this, Singh et al. [60] did not find any correlation between the number of follicles observed at the start of the FSH treatment and the number of corpora lutea. Also Fernandez et al. [22] found no significant correlation between the follicular population at the beginning of the treatment and the number of ovulations and embryo yield. Drawing a 595 considered, that the recommended time for time-oriented A.I. in Figure 4 is valid, when luteolysis is induced 48 h after the start of gonadotropin treatment.
6. Ablation of the dominant follicle prior to superovulatory treatment can increase the number of transferable embryos. But this treatment cannot reduce the variability after superstimulation, because the main reason for the variation of ovulation number consists in the number of follicles which respond to gonadotropins with proliferation, differentiation and ovulation in a period of 120 h. 7 . FSH application once a day can be as efficient as a twice daily application. The application regime has to be tested for each product.
